Pediatric palliative care is a specialized field focused on improving the quality of life for children with life-limiting or life-threatening conditions and their families. Unlike adult palliative care, which often begins near the end of life, pediatric palliative care is frequently initiated at the time of diagnosis of a chronic, life-shortening illness (such as spinal muscular atrophy or advanced pediatric oncology). For the pain physician, this requires a mastery of aggressive symptom management, a deep understanding of pediatric medical ethics, and the ability to navigate the complex emotional landscape of parental decision-making.

1. The Ethical Framework: Consent, Assent, and the Double Effect

The treatment of terminal pain in children involves unique legal and ethical considerations that differ from the adult model.

• Consent vs. Assent: While parents or legal guardians provide the formal legal consent for treatment, clinicians have an ethical obligation to seek the assent of the child whenever developmentally appropriate (usually age 7 and older). This involves explaining the treatment in age-appropriate terms and honoring the child’s preferences when they do not conflict with their best interests.
• The Principle of Double Effect: This is a high-yield board concept. It holds that an action with both a good effect (relieving pain) and a potentially bad effect (respiratory depression) is ethically permissible if:
  1. The action itself is good (administering analgesia).
  2. The clinician’s intent is purely for the good effect.
  3. The good effect is not achieved by means of the bad effect.
  4. There is a proportionately serious reason for the action (terminal pain).

2. Pain Management in the Terminal Phase

Pain is the most feared symptom in pediatric palliative care. The goal is to provide a “pain-free window” for the child to interact with their family.

• Opioid Titration: In the terminal phase, there is no “ceiling dose” for opioids. Dosing should be based on the child’s comfort rather than a predetermined numerical limit.
• The Routine vs. PRN Approach: For constant terminal pain, medication should be scheduled “around the clock” to prevent the emergence of “breakthrough” pain, which is much harder to control once established.
• Alternative Routes: As children lose the ability to swallow, clinicians should transition to less invasive but effective routes, such as sublingual, transdermal, or subcutaneous infusions (using a “butterfly” needle), rather than repeated intramuscular injections.

3. Managing Non-Pain Symptoms

In the final days of life, non-pain symptoms can be just as distressing as nociception.

• Dyspnea (Air Hunger): Opioids are the gold standard for treating the sensation of breathlessness. Low-dose morphine reduces the respiratory drive and the anxiety associated with air hunger without necessarily causing respiratory arrest.
• The “Death Rattle” (Terminal Secretions): Caused by the accumulation of saliva and bronchial secretions in the oropharynx. While often not distressing to the unconscious child, it is highly distressing to families. It is managed with anticholinergics like Glycopyrrolate (which does not cross the blood-brain barrier) or Scopolamine patches.
• Terminal Agitation: Managed with benzodiazepines (e.g., Midazolam) or antipsychotics (e.g., Haloperidol) to ensure the child is calm and settled.

4. Neuropathic Pain and Adjuvants

Many pediatric terminal illnesses, such as neuroblastoma or brainstem gliomas, involve significant neuropathic pain.

• Gabapentinoids: Used to reduce the “fire-like” or “electrical” component of tumor-related nerve compression.
• Corticosteroids: (e.g., Dexamethasone) are vital in palliative care for reducing peritumoral edema, improving appetite, and managing pain from bone metastases or increased intracranial pressure.

5. PM&R Integration: Quality of Life and Positioning

From a physiatric perspective, palliative care is about maximizing the child’s ability to engage with their environment for as long as possible.

• Adaptive Equipment: Providing specialized seating or “comfort beds” that prevent pressure injuries in a child who is no longer mobile.
• Gentle Range of Motion: Training parents in passive stretching to prevent painful contractures that can interfere with hygiene and diaper changes.
• The “Legacy” Focus: PM&R and Occupational Therapy focus on “occupations” of childhood, such as play or art, modified to the child’s energy levels, to help create lasting memories for the family.

6. Grief and Bereavement

A high-yield board concept is recognizing that palliative care does not end when the child passes away. Bereavement support for the parents and siblings is a mandatory component of a comprehensive palliative program. This includes identifying families at high risk for “complicated grief,” such as those with limited social support or those who experienced sudden, traumatic losses.

---

High-Yield Board “Fast Facts”

• Double Effect: The clinician’s intent must be to relieve suffering, not to hasten death.
• Glycopyrrolate: Preferred over scopolamine for terminal secretions if the clinician wants to avoid the sedative or “deliriogenic” effects of a drug crossing the blood-brain barrier.
• WHO Pain Ladder: While the ladder is used, pediatric palliative care often “jumps” to Step 3 (strong opioids) quickly for terminal cancer pain.
• Fentanyl Patches: Should only be used in opioid-tolerant children and never for acute, fluctuating pain due to the long time required to reach a steady state.